ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer.

Ge LP, Jin X, Ma D, Wang ZY, Liu CL, Zhou CZ, Zhao S, Yu TJ, Liu XY, Di GH, Shao ZM, Jiang YZ
Cell Res. 2024 Jan;34(1):58-75. doi: 10.1038/s41422-023-00909-w. Epub 2024 Jan 2. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.